# SiYOMiCRO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/siyomicro

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.siyobio.com
- Total disclosed funding: $32M
- Latest round: Series C (Jul 31, 2026)
- Investors on record: 5

## About

Based in Shenzhen, China, and founded in 2015, SIYOMICRO BIO-TECH Co., Ltd., trading as SiYOMiCRO, is a biotechnology company that focuses on synthetic biology field. Its founder is Mr. Dong Liang. The company has been recognized as a National High-Tech Enterprise, Specialized and Sophisticated Enterprise, and National “Little Giant” Enterprise. In July 2026, it raised hundreds of millions of CNY in a series C funding round.

SiYOMiCRO's product portfolio includes bioactive cosmetic ingredients, functional food ingredients, fermentation-derived biomolecules, biosurfactants, and specialty bio-based materials developed through microbial fermentation and synthetic biology technologies. Specific products include  ectoine, superoxide dismutase (SOD), and a-arbutin. The ectoine and SOD can prevent skin dryness and aging, used in cosmetics products. The a-arbutin has the effect of skin whitening and freckle removal.

The company’s revenue is generated through the development, production, and sale of bioactive ingredients and bio-based materials.

The company will use the series C funding to support the construction of its synthetic biology platform, further accelerating the development of multi-chassis cells and the industrialization of products, and completing the strategic layout for the production of bulk biopharmaceuticals.

## Funding rounds

- Series C, Jul 31, 2026 — Goldport Capital, Shenzhen Longgang District Guidance Fund Investment
- Series B, Feb 23, 2022, $32M — China International Capital Corporation, Aier Healthcare Investment Group, Sinvo Capital

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Aier Healthcare Investment Group — Series B
- Sinvo Capital (https://capitalatlas.ai/funds/sinvo-capital) — Series B
- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Series C
- Shenzhen Longgang District Guidance Fund Investment — Series C